Commonwealth Equity Services LLC Makes New $1.02 Million Investment in Embecta Corp. (NASDAQ:EMBC)

Commonwealth Equity Services LLC acquired a new stake in Embecta Corp. (NASDAQ:EMBC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 49,322 shares of the company's stock, valued at approximately $1,018,000. Commonwealth Equity Services LLC owned 0.08% of Embecta as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in EMBC. Raymond James Financial Inc. acquired a new position in Embecta in the fourth quarter valued at about $6,598,000. Meros Investment Management LP acquired a new position in shares of Embecta in the 3rd quarter valued at approximately $2,679,000. Jane Street Group LLC raised its position in shares of Embecta by 156.1% in the 3rd quarter. Jane Street Group LLC now owns 176,487 shares of the company's stock valued at $2,488,000 after buying an additional 107,567 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Embecta by 3.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,387,273 shares of the company's stock worth $19,564,000 after acquiring an additional 45,228 shares during the period. Finally, Garden State Investment Advisory Services LLC acquired a new stake in shares of Embecta during the 3rd quarter worth approximately $438,000. Institutional investors and hedge funds own 93.83% of the company's stock.

Embecta Price Performance

EMBC traded down $0.37 during trading on Friday, hitting $12.00. 1,414,450 shares of the stock traded hands, compared to its average volume of 446,761. The business has a 50 day moving average price of $14.62 and a 200 day moving average price of $16.14. Embecta Corp. has a twelve month low of $9.93 and a twelve month high of $21.48. The company has a market cap of $697.61 million, a price-to-earnings ratio of 12.00, a PEG ratio of 0.78 and a beta of 1.23.

Remove Ads

Embecta (NASDAQ:EMBC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.65 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.20. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. On average, equities research analysts predict that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.15 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 5.00%. Embecta's payout ratio is currently 60.00%.

Insider Activity at Embecta

In related news, Director Milton Mayo Morris sold 3,100 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total transaction of $50,778.00. Following the sale, the director now owns 36,133 shares of the company's stock, valued at $591,858.54. This trade represents a 7.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.42% of the stock is currently owned by insiders.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.